These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2870742)

  • 21. EEG coherence during hemispheric activation in schizophrenics.
    Michelogiannis S; Paritsis N; Trikas P
    Eur Arch Psychiatry Clin Neurosci; 1991; 241(1):31-4. PubMed ID: 1832303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain electrical activity changes in treatment refractory schizophrenics after olanzapine treatment.
    Cerdán LF; Guevara MA; Sanz A; Amezcua C; Ramos-Loyo J
    Int J Psychophysiol; 2005 Jun; 56(3):237-47. PubMed ID: 15866327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EEG-brain mapping. A method to optimize therapy in schizophrenics using absolute power and center frequency values.
    Schellenberg R; Schwarz A; Knorr W; Haufe C
    Schizophr Res; 1992 Oct; 8(1):21-9. PubMed ID: 1358183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of clozapine on cognitive function and regional cerebral blood flow in the negative symptom profile schizophrenia.
    Zhao J; He X; Liu Z; Yang D
    Int J Psychiatry Med; 2006; 36(2):171-81. PubMed ID: 17154147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. P300 delay and attenuation in schizophrenia: reversal by neuroleptic medication.
    Coburn KL; Shillcutt SD; Tucker KA; Estes KM; Brin FB; Merai P; Moore NC
    Biol Psychiatry; 1998 Sep; 44(6):466-74. PubMed ID: 9777178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evoked gamma band synchronization and the liability for schizophrenia.
    Hong LE; Summerfelt A; McMahon R; Adami H; Francis G; Elliott A; Buchanan RW; Thaker GK
    Schizophr Res; 2004 Oct; 70(2-3):293-302. PubMed ID: 15329305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human cortical EEG rhythms during long-term episodic memory task. A high-resolution EEG study of the HERA model.
    Babiloni C; Babiloni F; Carducci F; Cappa S; Cincotti F; Del Percio C; Miniussi C; Moretti DV; Pasqualetti P; Rossi S; Sosta K; Rossini PM
    Neuroimage; 2004 Apr; 21(4):1576-84. PubMed ID: 15050581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of illness duration on perceptual asymmetry in schizophrenia.
    Carr V; Wale J; Dewis S; Stephan L
    Schizophr Res; 1992 Sep; 7(3):211-6. PubMed ID: 1356424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of untreated and treated schizophrenic patients, normals, and neuroleptic-treated normals: "hypofrontality" and different EEG spectra before and during voluntary movement.
    Westphal KP; Groezinger B; Diekmann V; Scherb W; Rees J; Leibing U; Kornhuber HH
    Psychiatry Res; 1989 Sep; 29(3):395-8. PubMed ID: 2608800
    [No Abstract]   [Full Text] [Related]  

  • 30. Single photon emission computed tomography (SPECT) measures of brain function in schizophrenia.
    Gordon E; Barry RJ; Anderson J; Fawdry R; Yong C; Grunewald S; Meares RA
    Aust N Z J Psychiatry; 1994 Sep; 28(3):446-52. PubMed ID: 7893239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Slower theta activity over the midfrontal cortex in schizophrenic patients.
    Westphal KP; Grözinger B; Diekmann V; Scherb W; Reess J; Leibing U; Kornhuber HH
    Acta Psychiatr Scand; 1990 Feb; 81(2):132-8. PubMed ID: 2327275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Telemetered EEG in schizophrenia: spectral analysis during abnormal behaviour episodes.
    Stevens JR; Livermore A
    J Neurol Neurosurg Psychiatry; 1982 May; 45(5):385-95. PubMed ID: 7086451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EEG- and EP-mapping--possible indicators for disturbed information processing in schizophrenia?
    Schellenberg R; Schwarz A
    Prog Neuropsychopharmacol Biol Psychiatry; 1993 Jul; 17(4):595-607. PubMed ID: 8103234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical, EEG mapping and psychometric studies in negative schizophrenia: comparative trials with amisulpride and fluphenazine.
    Saletu B; Küfferle B; Grünberger J; Földes P; Topitz A; Anderer P
    Neuropsychobiology; 1994; 29(3):125-35. PubMed ID: 7912819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Latency increase of auditory-evoked potential component N1 predicts poor neuroleptic response in schizophrenic patients.
    Adler G; Markert U; Gattaz WF
    Pharmacopsychiatry; 1994 Mar; 27(2):68-9. PubMed ID: 7913236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroleptic-like electroencephalographic changes in schizophrenics through biofeedback.
    Schneider SJ; Pope AT
    Biofeedback Self Regul; 1982 Dec; 7(4):479-90. PubMed ID: 6131700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three-dimensional localization of abnormal EEG activity in migraine: a low resolution electromagnetic tomography (LORETA) study of migraine patients in the pain-free interval.
    Clemens B; Bánk J; Piros P; Bessenyei M; Veto S; Tóth M; Kondákor I
    Brain Topogr; 2008 Sep; 21(1):36-42. PubMed ID: 18679787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormal EEG lateralization in boys with autism.
    Stroganova TA; Nygren G; Tsetlin MM; Posikera IN; Gillberg C; Elam M; Orekhova EV
    Clin Neurophysiol; 2007 Aug; 118(8):1842-54. PubMed ID: 17581774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EEG coherence of prefrontal areas in normal and schizophrenic males during perceptual activation.
    Hoffman RE; Buchsbaum MS; Escobar MD; Makuch RW; Nuechterlein KH; Guich SM
    J Neuropsychiatry Clin Neurosci; 1991; 3(2):169-75. PubMed ID: 1821231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative EEG in never-treated schizophrenic patients.
    Omori M; Koshino Y; Murata T; Murata I; Nishio M; Sakamoto K; Horie T; Isaki K
    Biol Psychiatry; 1995 Sep; 38(5):305-9. PubMed ID: 7495924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.